Abstract
Activated microglia is considered to be involved in the progression of Alzheimer's disease (AD). We investigated the effect of amyloid-β1-40 (Aβ40) and exogenous agonists of Toll-like receptor (TLR) 1/2 (Pam3CSK4) and TLR4 (LPS) on neurons in primary murine neuron-microglia co-cultures. Neuronal viability, assessed by quantifying the number of intact neuronal extensions and their crossings using a newly developed Definiens Cognition Network Technology-based method, was significantly decreased after treatment with Pam3CSK4, LPS, and Aβ40. Combined treatment with Aβ40 and Pam3CSK4 or LPS had an additive effect. Hence, in patients with AD, synergistic microglial activation by Aβ and bacterial products during infections might contribute to disease progression.
Keywords
Get full access to this article
View all access options for this article.
